This application is the U.S. National Phase application under 35 U.S.C. § 371 of International Application No. PCT/EP2015/062313, filed on Jun. 3, 2015, which claims the benefit of European Application No. 14171193.7 filed on Jun. 4, 2014. These applications are hereby incorporated by reference herein.
The invention relates a device for skin treatment, in particular for radio frequency (RF) treatment of human skin. The device is primarily suitable for skin tightening and/or skin rejuvenation, in particular for fractional RF skin treatment. The invention also relates to the use of such a device for skin treatment.
Radio frequency (RF) is conventionally used in both the professional and home-use aesthetic market for skin tightening. The ability to heat a large volume at dermal skin level has made the radio frequency technology the standard for skin tightening and for treating skin laxity. Compared to laser treatments, RF devices have a relatively lower cost price and can provide larger-volume and deeper tissue contraction. Additionally, RF energy dissipation does not rely on absorption of light by chromophores, so that tissue pigmentation or the vascular network does not interfere with the delivery of energy.
The basic principle of RF energy delivery at the skin surface and from there to tissue is that an alternating current is applied in a closed circuit with the skin. Tissue impedance directly affects the extent of the heating: RF propagates more easily through tissues with high conductivity (low electrical resistance), while tissues with high electrical resistance (high impedance, low conductance) are poor conductors of RF energy. RF energy takes the path of least resistance through skin tissue and is dissipated as thermal energy primarily due to molecular vibrations.
A growing application for RF beyond skin tightening is skin rejuvenation. In most RF skin rejuvenation devices, fractional thermal lesions in the skin are created simultaneously using small electrodes. Recently different professional devices have been launched onto the aesthetic market to address skin rejuvenation with a radio frequency device. Skin rejuvenation is a combination of different consumer benefits such as: even skin tone, reduction of pigmentation spots, improved radiance and texture and reduction of fine lines. Here the energy is used primarily to damage the stratum corneum and the epidermis (including the dermal-epidermal junction) and possibly the top part of the dermis. Traditionally, skin rejuvenation treatments are done by ablative or non-ablative settings of a laser wavelength highly absorbed by water, whereby the ablative treatments vaporize the skin and create hollow pillars in the skin and the non-ablative treatments heat the skin to 65-100° C. to initiate cell necrosis, collagen denaturation and contraction, and eventually collagen remodeling.
To date, fractional skin treatments using RF are limited to professional use. One possible reason is the safety of the treatment to ensure that the RF heating does not result in ablative damage to the skin tissue. This is particularly challenging since the amount of RF energy deposited in the tissue depends on local tissue impedance, and skin tissues have inhomogeneous impedance distribution. This uncertainty in impedance combined with the use of high current densities and voltages results in uncertainty in achieved temperatures in skin tissues during treatment, resulting in the occurrence of both non-ablative thermal lesions and the undesirable ablative tissue damages.
Patent application WO 2012/023129 describes an apparatus for personal aesthetic skin treatment by RF voltage. The apparatus includes an assembly of individual electrodes operative to contact fractions of the skin and deliver RF treatment voltage to each fraction. In a test mode of the apparatus, a test voltage is applied to the electrodes enabling determination of the quality of the contact between each of the electrodes and the skin. In the test mode no thermal lesions are generated in the skin. In a treatment mode, following the test mode, a treatment voltage is applied to generate thermal lesions in the skin. The test voltage does not exceed 50 Volt. The applied treatment voltage has higher values which lie between 50 Volt and 400 Volt.
It is an object of the invention to provide a device for RF skin treatment with improved safety in that it enables the generation of non-ablative fractionated skin lesions particularly by using a lower RF treatment voltage as compared to known devices, so that a feedback or monitoring system to detect proper contact between the electrodes and the skin is not required. For this purpose, according to a first aspect of the invention, a device for RF skin treatment is provided comprising an outer electrode arranged on an operational side of the device and having an annular or equilateral polygonal shape. The device comprises an inner electrode arranged on the operational side of the device at a center of the outer electrode and surrounded by the outer electrode. An RF generator is arranged to supply an RF treatment voltage between the inner electrode and the outer electrode. A skin contact surface of the inner electrode has a largest cross-sectional dimension in a range of 200-500 μm, and the RF treatment voltage is less than 50 V. In an embodiment, the skin contact surface of the inner electrode is circular. In this embodiment, the largest cross-sectional dimension of the skin contact surface corresponds to a diameter of the skin contact surface and is in said range of 200-500 μm. The circular inner electrode may be annular (i.e. ring shaped) or disc shaped (i.e. having the shape of a filled circle). The inner electrode may also be non-circular, for example square-shaped, having a largest cross-sectional dimension within the range as mentioned above.
The proposed range of the largest cross-sectional dimension of the skin contact surface of the inner electrode of 200-500 μm enables, in combination with a relatively low treatment voltage of below 50 Volts, the generation of thermal lesions that are large enough for effective skin rejuvenation and small enough to enable fast recovery of the skin.
The inner and outer electrodes are configured to simultaneously make contact to the skin. The actual skin contact surface of the inner electrode does not need to be flat. It may be curved. This also applies to the actual skin contact surface of the outer electrode. In this respect, when the skin contact surface is flat, the expression “a largest cross-sectional dimension of the skin contact surface” refers to a largest dimension of the skin contact surface measured in the plane of the skin contact surface. When the skin contact surface is not flat, in particular when it is curved, the expression “a largest cross-sectional dimension of the skin contact surface” refers to a largest dimension measured in a cross-section of the inner electrode containing the outer circumference of the skin contact surface.
In an embodiment, the largest cross-sectional dimension of the skin contact surface of the inner electrode is in a range of 200-400 μm. Values for the largest cross-sectional dimension of the skin contact surface of the inner electrode within this preferred range have shown good results in ex-vivo skin tests.
In an embodiment, the RF treatment voltage is 40 V or less, such as 39 V. The above mentioned values for the largest cross-sectional dimension of the skin contact surface of the inner electrode enable sufficient warming of the skin, even with relatively low treatment voltages. It should be noted that the treatment voltage should not be too low, because in order to create lesions a sufficient amount of energy is required. Preferably the RF treatment voltage should not be lower than 20 volts when the RF exposure is less than 1 s.
In an embodiment, a ratio between a skin contact surface of the outer electrode and the skin contact surface of the inner electrode is greater than 2 and preferably greater than 10. In this way, there will be no discomfort by undesired heating in portions of the skin present beneath the outer electrode.
In an embodiment, a minimum distance between an outer edge of the inner electrode and an inner edge of the outer electrode is greater than 0.1 mm, more preferably greater than 0.2 mm. In a further embodiment, said minimum distance between the outer edge of the inner electrode and the inner edge of the outer electrode is smaller than 3 mm. There is no strict technical upper limit to said minimum distance (also referred to as gap between the inner and the outer electrodes), but for practical reasons to enable sufficient density of lesions from a grid of electrodes, for skin rejuvenation applications the gap should be smaller than 3 mm.
In an embodiment, the device comprises a plurality of inner electrodes and a plurality of outer electrodes, each of the plurality of outer electrodes surrounding a respective one of the plurality of inner electrodes. In this embodiment, at least some of the plurality of outer electrodes may be electrically connected to each other. In a preferred embodiment, the at least some of the plurality of outer electrodes may border each other so as to form a lattice structure. These embodiments require less wiring from the RF generator to the outer electrodes. Furthermore, more electrodes can be arranged on the same surface as compared to separate outer electrodes.
According to a second aspect, the invention relates to the use of the device as described above in the treatment of skin. The device may be used for therapeutic or non-therapeutic (e.g. cosmetic) treatment. The device is especially useful for rejuvenation of the skin, but may also be used for skin tightening.
Further preferred embodiments of the device and method according to the invention are described in the appended claims, disclosure of which is incorporated herein by reference.
These and other aspects of the invention will be apparent from and elucidated further with reference to the embodiments described by way of example in the following description and with reference to the accompanying drawings, in which
The figures are purely diagrammatic and not drawn to scale. In the Figures, elements which correspond to elements already described may have the same reference numerals.
It is noted that in most embodiments the inner electrode 1 will be the active electrode (i.e. the electrode connected to the live wire), while the outer electrode 2 is the return electrode, but this could be the other way round.
To create multiple lesions concurrently, the device may comprise a plurality of inner electrodes, wherein each inner electrode is surrounded by a respective one of a plurality of outer electrodes.
By arranging a plurality of inner electrodes 31 on the operational side 15 of the device 100 and surrounding each by an outer electrode 32, a larger skin surface can be treated at one time as compared to devices that comprise only one electrode pair.
At the bottom, the device 40 comprises an inner electrode 46 and an outer electrode 47 provided on an operational side 45 of the device 40. The inner electrode 46 and the outer electrode 47 may be configured as described above. The device 40 also comprises a button 44 that can be activated in order to provide pulses of RF energy between the inner and outer electrodes 46, 47.
The device 40 has an elongated shape which, when suitably dimensioned, can be used like a pen which can be brought into contact with the skin. This embodiment is especially useful as a home-use handheld skin treatment device for skin rejuvenation.
In an embodiment, a ratio between the skin contact surface of the outer electrode 47 and the skin contact surface of the inner electrode 46 is greater than 2, and preferably greater than 10.
The device described above was tested by performing ex-vivo experiments. These ex-vivo experiments have shown robust lesion creation at voltages of 40V or less, and the impedance variations within both ex-vivo and in-vivo skin models investigated are within the +/−25% range.
The invention also relates to the use of the device according to the embodiments described above for RF treatment of skin. The device is especially useful for rejuvenation of the skin.
When using the device for RF skin treatment, a contact gel may be used, preferably a conductive gel, to improve the local skin impedance and the electrical contact between the skin and the device.
It is noted that in this document the word ‘comprising’ does not exclude the presence of elements or steps other than those listed, and the word ‘a’ or ‘an’ preceding an element does not exclude the presence of a plurality of such elements, and it is also noted that any reference signs do not limit the scope of the claims. Further, the invention is not limited to the embodiments, and the invention lies in each and every novel feature or combination of features described above or recited in mutually different dependent claims.
Number | Date | Country | Kind |
---|---|---|---|
14171193 | Jun 2014 | EP | regional |
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/EP2015/062313 | 6/3/2015 | WO |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2015/185583 | 12/10/2015 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
6228078 | Eggers | May 2001 | B1 |
6413255 | Stern | Jul 2002 | B1 |
20040002746 | Ryan | Jan 2004 | A1 |
20040019371 | Jaafar | Jan 2004 | A1 |
20070206986 | Gueret | Sep 2007 | A1 |
20080183167 | Britva | Jul 2008 | A1 |
20080183251 | Azar | Jul 2008 | A1 |
20100010480 | Mehta | Jan 2010 | A1 |
20100016849 | Rosenberg | Jan 2010 | A1 |
20110009860 | Chornenky | Jan 2011 | A1 |
20110015625 | Adanny | Jan 2011 | A1 |
20120185029 | Flyash | Jul 2012 | A1 |
20130079766 | Adanny | Mar 2013 | A1 |
20130226269 | Eckhouse | Aug 2013 | A1 |
20130289679 | Eckhouse | Oct 2013 | A1 |
20140005658 | Rosenbegr | Jan 2014 | A1 |
20140207217 | Lischinsky | Jul 2014 | A1 |
20170189704 | Palero | Jul 2017 | A1 |
20170202606 | Horton | Jul 2017 | A1 |
20180110977 | Palero | Apr 2018 | A1 |
20180207421 | Jurna | Jul 2018 | A1 |
Number | Date | Country |
---|---|---|
102011053731 | Mar 2013 | DE |
101227224 | Jan 2013 | KR |
2012023129 | Feb 2012 | WO |
2012052986 | Apr 2012 | WO |
20140207217 | Jul 2014 | WO |
Number | Date | Country | |
---|---|---|---|
20170189668 A1 | Jul 2017 | US |